Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Viwit Zhike Pharmaceutical is a core subsidiary of the Viwit Pharmaceutical Group, specializing in the research, development, and manufacturing of finished dosage forms. The company is particularly recognized for its strong presence in the ophthalmic therapeutic area, producing a variety of eye drops for conditions like glaucoma and allergic conjunctivitis. Located in Zaozhuang, Shandong, it operates advanced manufacturing facilities that comply with international GMP standards. Viwit Zhike benefits from the parent group's vertically integrated business model, which ensures a stable supply of high-quality active pharmaceutical ingredients (APIs) and intermediates. Their product line includes generic versions of major ophthalmic drugs, contributing to increased accessibility for patients globally. The company continues to expand its portfolio through internal R&D and strategic collaborations within the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 山东威智知科药业.